Chinook is developing precision medicines for kidney diseases. The company is applying its proprietary discovery platform, which leverages single cell RNA sequencing, human-derived organoids and new translational models, to discover and develop therapeutics with novel mechanisms of action against key disease pathways in kidney disease.

Company Name

Chinook Therapeutics (KDNY)


Vancouver, Canada

Investment Stage

Public listing October 2020